Expression of Alternatively Spliced Human Tissue Factor
选择性剪接的人组织因子的表达
基本信息
- 批准号:6868044
- 负责人:
- 金额:$ 11.04万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2005
- 资助国家:美国
- 起止时间:2005-02-07 至 2009-01-31
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
DESCRIPTION (provided by applicant):
I, Vladimir Bogdanov, am applying for this research development award in order to finalize my transition into an independent research scientist. The immediate goals are: 1) to acquire new laboratory skills and generate novel research data that would enable me to compete for regular research project grant support (RO1), 2) to acquire first-hand experience in being a principal investigator, and 3) to make substantial progress in elucidating the mechanisms involved in regulation of human tissue factor (TF) pre-mRNA processing in monocytic cells. Specifically, I propose to study regulatory mechanisms responsible for generation of alternatively spliced human tissue factor (asHTF) in monocytes. asHTF, a recently identified molecule, is a soluble, biologically active form of human tissue factor generated by alternative splicing. It is present in circulating blood and thrombi and interacts with platelets under shear conditions. Full-length membrane-bound TF and asHTF are both present in arterial and ex-vivo thrombi. Initial results show that circulating monocytes serve as one of the major sources of asHTF protein in human plasma. Thus, mechanics of tissue factor pre-mRNA splicing in monocytic cells is the primary research objective of the proposed study. In addition, I propose to achieve selective down-regulation of full-length membrane bound TF and asHTF mRNA in monocytic cells by a novel technique of RNA interference and assess the impact of this down-regulation on the total coagulant potential of monocytic cells.
描述(由申请人提供):
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
VLADIMIR BOGDANOV其他文献
VLADIMIR BOGDANOV的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('VLADIMIR BOGDANOV', 18)}}的其他基金
Post-Graduate Hematology/Oncology Translational (PG-HOT) Training Program
研究生血液学/肿瘤学转化 (PG-HOT) 培训计划
- 批准号:
10433906 - 财政年份:2019
- 资助金额:
$ 11.04万 - 项目类别:
Post-Graduate Hematology/Oncology Translational (PG-HOT) Training Program
研究生血液学/肿瘤学转化 (PG-HOT) 培训计划
- 批准号:
10218114 - 财政年份:2019
- 资助金额:
$ 11.04万 - 项目类别:
Post-Graduate Hematology/Oncology Translational (PG-HOT) Training Program
研究生血液学/肿瘤学转化 (PG-HOT) 培训计划
- 批准号:
9973158 - 财政年份:2019
- 资助金额:
$ 11.04万 - 项目类别:
Post-Graduate Hematology/Oncology Translational (PG-HOT) Training Program
研究生血液学/肿瘤学转化 (PG-HOT) 培训计划
- 批准号:
10647668 - 财政年份:2019
- 资助金额:
$ 11.04万 - 项目类别:
Alternatively Spliced Tissue Factor and Pathobiology of Pancreatic Cancer
选择性剪接的组织因子与胰腺癌的病理学
- 批准号:
9247762 - 财政年份:2015
- 资助金额:
$ 11.04万 - 项目类别:
Alternatively Spliced Tissue Factor and Pathobiology of Pancreatic Cancer
选择性剪接的组织因子与胰腺癌的病理学
- 批准号:
8799911 - 财政年份:2015
- 资助金额:
$ 11.04万 - 项目类别:
Alternatively Spliced Tissue Factor and Pathobiology of Pancreatic Cancer
选择性剪接的组织因子与胰腺癌的病理学
- 批准号:
9052161 - 财政年份:2015
- 资助金额:
$ 11.04万 - 项目类别:
Tissue Factor splicing and pancreatic tumor progression: pilot studies
组织因子剪接和胰腺肿瘤进展:初步研究
- 批准号:
8508892 - 财政年份:2012
- 资助金额:
$ 11.04万 - 项目类别:
Tissue Factor splicing and pancreatic tumor progression: pilot studies
组织因子剪接和胰腺肿瘤进展:初步研究
- 批准号:
8384935 - 财政年份:2012
- 资助金额:
$ 11.04万 - 项目类别:
Inducible transgenes expressing EJC enriched mRNAs: a post-genomic innovation
表达 EJC 富集 mRNA 的诱导转基因:后基因组创新
- 批准号:
7737918 - 财政年份:2009
- 资助金额:
$ 11.04万 - 项目类别:
相似海外基金
Mechanisms of messenger RNA splicing and RNA processing regulation
信使RNA剪接和RNA加工调控机制
- 批准号:
10623834 - 财政年份:2023
- 资助金额:
$ 11.04万 - 项目类别:
Collaborative Research: Connecting the sequence logic of RNA splicing to nuclear localization
合作研究:将 RNA 剪接的序列逻辑与核定位联系起来
- 批准号:
2246530 - 财政年份:2023
- 资助金额:
$ 11.04万 - 项目类别:
Standard Grant
Collaborative Research: Connecting the sequence logic of RNA splicing to nuclear localization
合作研究:将 RNA 剪接的序列逻辑与核定位联系起来
- 批准号:
2246531 - 财政年份:2023
- 资助金额:
$ 11.04万 - 项目类别:
Standard Grant
Analysis on how RNA splicing factors change global gene expression patterns and regulate male fertility.
分析RNA剪接因子如何改变全局基因表达模式并调节男性生育能力。
- 批准号:
2882792 - 财政年份:2023
- 资助金额:
$ 11.04万 - 项目类别:
Studentship
Aberrant RNA splicing in sporadic inclusion body myositis
散发性包涵体肌炎中的异常RNA剪接
- 批准号:
23K18260 - 财政年份:2023
- 资助金额:
$ 11.04万 - 项目类别:
Grant-in-Aid for Challenging Research (Exploratory)
Synthetic introns for selective targeting of RNA splicing factor-mutant leukemia
用于选择性靶向RNA剪接因子突变型白血病的合成内含子
- 批准号:
10722782 - 财政年份:2023
- 资助金额:
$ 11.04万 - 项目类别:
Cancer immune therapeutics targeting aberrant RNA splicing products
针对异常 RNA 剪接产物的癌症免疫疗法
- 批准号:
23H02688 - 财政年份:2023
- 资助金额:
$ 11.04万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
RNA splicing regulation during alcohol withdrawal
酒精戒断过程中的 RNA 剪接调节
- 批准号:
10785159 - 财政年份:2023
- 资助金额:
$ 11.04万 - 项目类别:
Targeting Dysregulated RNA Splicing in Neurodegenerative Diseases
靶向神经退行性疾病中失调的 RNA 剪接
- 批准号:
10729566 - 财政年份:2023
- 资助金额:
$ 11.04万 - 项目类别:
Srsf3-mediated alternative RNA splicing in craniofacial development
Srsf3介导的颅面发育中的选择性RNA剪接
- 批准号:
10650417 - 财政年份:2022
- 资助金额:
$ 11.04万 - 项目类别:














{{item.name}}会员




